Study guide

Coats disease and leukocoria assessment

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Coats disease and leukocoria assessment

Key Takeaways Explain This Topic AI

Coats disease causes telangiectasia, exudation and potentially an exudative detachment.

Absent calcification does not exclude retinoblastoma, and childhood leukocoria needs prompt specialist assessment.

Treatment follows exudative stage and visual potential, with attention to traction and complications.

Last updated: October 2026

Coats Disease

Coats disease is a rare, idiopathic, non-hereditary retinal vascular anomaly characterized by progressive aneurysmal dilatations of retinal vessels, telangiectatic capillary malformations, and massive intraretinal and subretinal lipid exudation, ultimately culminating in exudative retinal detachment.

Epidemiology & Demographics

Gender Predilection: Strong male predominance, with approximately 80% to 85% of cases occurring in males (male-to-female ratio ~3:1 to 4:1).

Laterality: Overwhelmingly unilateral (85% to 90%) ; bilateral cases are exceedingly rare and should prompt investigation for underlying systemic or genetic vitreoretinopathies (such as facioscapulohumeral muscular dystrophy [FSHD] or familial exudative vitreoretinopathy [FEVR]).

Age of Onset: Most commonly diagnosed in young children during the first decade of life (peak age 6 to 8 years ). However, a bimodal age distribution exists: an early, aggressive paediatric form, and a milder, indolent presentation diagnosed in young-to-middle-aged adults.

Cellular Pathophysiology & Vascular Malformations

The fundamental pathological defect in Coats disease is primary endothelial cell failure and loss of vascular pericytes within the retinal microvasculature:

Inner Blood-Retinal Barrier Breakdown: Somatic mutations in the NDP gene (Norrie disease protein / norrin) have been identified in some patients. Endothelial tight junctions disassemble, leading to catastrophic breakdown of the inner blood-retinal barrier.

"Lightbulb" Telangiectasias: Capillaries, venules, and arterioles undergo localized ectasia, saccular outpouchings, and fusiform aneurysmal dilatation, creating the characteristic "lightbulb" telangiectatic vessels typically located in the temporal and inferior mid-periphery.

Massive Lipid Exudation: The incompetent, leaky telangiectasias pour plasma constituents, cholesterol, and lipoproteins into the retina. Lipid precipitates into enormous, glistening, yellowish-white mounds in the outer plexiform layer and subretinal space, often gravitating to the fovea to form a massive subfoveal lipid plaque.

Exudative Retinal Detachment: Progressive accumulation of proteinaceous, amber subretinal fluid separates the neurosensory retina from the underlying RPE without any retinal tears or holes (non-rhegmatogenous, bullous serous detachment).

The Critical Differential Diagnosis: Coats Disease vs. Retinoblastoma

Differentiating Coats disease from retinoblastoma is one of the most critical life-and-death diagnostic challenges in paediatric ophthalmology. Both conditions present with leukocoria (white pupillary reflex) or strabismus in young children:

Diagnostic Parameter Coats Disease Retinoblastoma

Biological Nature Benign idiopathic exudative vasculopathy Malignant intraocular neuroblastic tumour ( RB1 gene mutation)

Intraocular calcification Usually absent, but exceptions occur Common, but its absence does not exclude retinoblastoma; use specialist examination, ultrasound and appropriate MRI

Fundus Biomicroscopy Prominent "lightbulb" telangiectasias, aneurysmal beading, and massive yellow lipid mounds Solid, chalky-white or fleshy pink retinal mass; endophytic or exophytic; abnormal tumour vessels

Exudation Characteristics Enormous yellow lipid exudates and cholesterol crystals in clear/amber fluid Clear subretinal fluid; lipid exudation is distinctly absent

Vitreous Findings Clear vitreous; absence of cellular seeds Vitreous seeding (discrete, floating tumour clumps) in endophytic forms

Anterior Segment Clear anterior chamber until late stages; normal iris May show tumour pseudohypopyon, iris nodules, or spontaneous hyphaema

Eye Size (Ultrasonography) Normal axial length for age Normal axial length for age

Caution

A child with uncertain leukocoria requires urgent ocular-oncology assessment. Do not biopsy a suspected retinoblastoma or infer benignity from absent calcium. Imaging and examination guide management; uncertainty alone does not prescribe an automatic enucleation in every eye.

Shields Staging System & Management Paradigms in Coats Disease

The Shields classification provides a rigorous framework for staging and therapeutic intervention:

Stage 1 (Telangiectasia only): Telangiectatic and aneurysmal vessels without intraretinal or subretinal exudation. Managed with direct argon or diode green/yellow laser photocoagulation applied to the telangiectatic vessels to obliterate abnormal flow.

Stage 2 (Telangiectasia and exudation):

Stage 2A: Extrafoveal exudation. Treated with confluent focal laser photocoagulation or transscleral cryotherapy to the abnormal peripheral telangiectatic beds.

Stage 2B: Foveal exudation. The offending peripheral telangiectasias are aggressively ablated. Direct laser to the fovea is strictly avoided ; resorption of subfoveal lipid occurs slowly after vascular leakage is controlled; the interval varies and established foveal damage can persist. Anti-VEGF can be considered selectively as an adjunct, with attention to traction/fibrosis risk; control of abnormal leaking vessels remains central.

Stage 3 (Exudative Retinal Detachment):

Stage 3A: Subtotal exudative detachment (3A1: extrafoveal; 3A2: involving the fovea). Managed with transscleral cryotherapy (double freeze-thaw) to anterior telangiectasias where subretinal fluid prevents laser uptake, with anti-VEGF considered selectively as an adjunct; discuss traction/fibrosis risk and the need to treat leaking vessels.

Stage 3B: Total bullous exudative retinal detachment. Requires surgical intervention: external transscleral subretinal fluid drainage (via sclerotomy) or 23/25-gauge pars plana vitrectomy with internal drainage, endolaser ablation of telangiectasias, and temporary silicone oil tamponade.

Stage 4 (Total detachment with secondary glaucoma): Closed-angle neovascular glaucoma secondary to iris rubeosis or forward displacement of the lens-iris diaphragm. Managed with cyclodestructive procedures (transscleral diode cyclophotocoagulation) or enucleation for blind, painful eyes.

Stage 5 (End-stage): Phthisis bulbi, band keratopathy, cataracts, and complete globe disorganization. Observation or enucleation for intractable pain.